Combination of pGL1-TNF-α gene and radiation (proton and γ-ray) therapy against brain tumor

Anticancer Research

Volumn 20, Issue 6 B, 2000, Pages 4195-4204

  Gridley, D S ^a   Li, J ^a   Kajioka, E H ^a   Andres, M L ^a   Moyers, M F ^a   Slater, J M ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain tumor; Gene therapy; Ionizing radiation; Proton radiation; TNF

Indexed keywords

PLASMID VECTOR; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY MASS; BRAIN TUMOR; CANCER GRAFT; CANCER INHIBITION; CANCER RADIOTHERAPY; FLOW CYTOMETRY; GAMMA RADIATION; GENE THERAPY; GLIOMA; IONIZING RADIATION; LYMPHOCYTE TRANSFORMATION; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTON RADIATION; RADIATION DOSE; RAT; SPLEEN SIZE;

ANIMALS; BODY WEIGHT; BRAIN NEOPLASMS; COBALT RADIOISOTOPES; COMBINED MODALITY THERAPY; GENE THERAPY; GENETIC VECTORS; GLIOMA; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MALE; MICE; MICE, NUDE; PHOTONS; PROTONS; RATS; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034483278     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Cancer statistics 1999
2. Brain tumors
3. Brain tumors in children
4. Radiosurgery as part of the initial management of patients with malignant gliomas
5. Primary central nervous system tumours: Advances in knowledge and treatment
6. Incidence of second primary tumors among childhood cancer survivors
7. Brain tumors in children
8. Tolerance of the central and peripheral nervous system to therapeutic irradiation
9. Role for proton beam irradiation in treatment of pediatric CNS malignancies
10. Potentialities of proton radiotherapy
11. Proton-beam irradiation for the cancer patient: An approach to optimal therapy and normal-tissue sparing
12. Development of a hospital-based proton beam treatment center
13. The proton treatment center at Loma Linda University Medical Center: Rationale for and description of its development
14. Anti-tumor effects of tumor necrosis factor alone or combined with radiotherapy
15. Interaction of tumor necrosis factor-α and radiation against human colon tumor cells
16. Effects of tumor necrosis factor-α and radiation on human tumor xenografts
17. Enhancement of prostate cancer xenograft growth with whole-body radiation and vascular endothelial growth factor
18. Tumor necrosis factor-α enhances the anti-tumor effects of radiation against glioma xenografts
19. Genetic radiotherapy overcomes tumor resistance to cytotoxic agents
20. Tumor necrosis factor-α (TNF-α) gene therapy targeted by ionizing radiation selectively damages tumor vasculature
21. An endotoxin induced serum factor that causes necrosis of tumors
22. Immunomodulatory properties of recombinant murine and human tumor necrosis factor
23. Immune functions of tumor necrosis factor
24. Phase I clinical trial of recombinant human necrosis factor
25. Phase II studies of recombinant human tumor necrosis factor alpha in patients with malignant disease: A summary of the southwest oncology group experience
26. Gene therapy for brain tumors
27. Gene therapy for gliomas: Molecular targets, adenoviral vectors, and oncolytic adenoviruses
28. Gene therapy of genetic diseases and cancer
29. Nonviral gene therapy: Promises and challenges
30. A model using radiation and plasmid-mediated tumor necrosis factor-α gene therapy for treatment of glioblastoma
31. Differentiated rat glial cell strain in tissue culture
32. Downstream insertion of the adenovirus tripartite leader sequence enhances expression in universal eukaryotic vectors
33. Evaluation of pGL1-TNF-α therapy in combination with radiation
34. Effects of proton and gamma radiation on lymphocyte population and acute response to antigen. In Vivo
35. The interaction between human recombinant tumor necrosis factor and radiation in 13 human tumor cell lines
36. Phase I dose-escalation study of tumor necrosis factor-α and concomitant radiation therapy
37. Evaluation of tumor necrosis factor-α and radiation efficacy in a human lung adenocarcinoma model
38. Immunotherapy and gene therapy for cancer
39. Tumor suppression after tumor cell-targeted tumor necrosis factor a gene transfer
40. Expression of the tumor necrosis factor gene in tumor cells correlates with reduced tumorigenicity and reduced invasiveness in vivo
41. Relative biological effectiveness of proton beams in clinical therapy
42. Calculation of relative biological effectiveness for proton beams using biological weighting functions
43. Proton radiation therapy for chordomas and chondrosarcomas of the skull base
44. Potential for gain in the use of proton beam boost to the para-aortic lymph nodes in carcinoma of the cervix
45. Treatment of macular degeneration with proton beams
46. Conformal proton therapy for prostate carcinoma
47. Phase I/II study of proton beam irradiation for the treatment of subfoveal choroidal neovascularization in age-related macular degeneration: Treatment techniques and preliminary results
48. Combined proton and photon conformal radiation therapy for locally advanced carcinoma of the prostate: Preliminary results of a phase I/II study
49. pGL1-TNF-α gene therapy and radiation in a malignant brain tumor model
50. Tumor necrosis factor a-mediated tumor regression by the in vivo transfer of genes into the artery that leads to tumors
51. Theta-bearing lymphocytes in nude mice
52. T cells. I. T-cell differentiation and function
53. Postthymic T-cell development